Autres langues Shilpa Medicare Limited

Actions

SHILPAMED

INE790G01031

Marché Fermé - Bombay S.E. Autres places de cotation 12:00:49 26/04/2024			Varia. 5j.	Varia. 1 janv.
545,5 ^INR	+2,86 %		+2,05 %	+65,10 %

09/04	Shilpa Medicare reçoit le feu vert du conseil d'administration pour lancer un QIP	MT
28/03	La branche sciences de la vie de Shilpa Medicare nomme son PDG	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US	18/04
Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit	17/04
Shilpa Medicare Gets Board Nod to Launch QIP	09/04
Shilpa Medicare's Life Science Arm Names CEO	28/03
Shilpa Medicare's New Unit in Hyderabad, India Gets Zero Observations from US FDA	01/03
Shilpa Medicare Gets Approval to Market Smoking Cessation Drug in Europe	26/02
Shilpa Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
Shilpa Medicare Gets Germany's Marketing Approval for Rare Muscles Diseases Drug	19/01
Shilpa Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	10/11
Shilpa Medicare Acquires US-Based Pilnova Pharma	03/11
Shilpa Medicare Limited Launches Naturally Derived Option for the Treatment of Oral Mucositis in India Under the Brand Name Oraal	11/10/23
Shilpa Medicare Unit's API Manufacturing Plant Gets Clearance from Japanese Drug Regulator's Inspection	04/09/23
Shilpa Medicare Gets UK Drug Regulator's Nod to Market Drug for Meniere's Syndrome Symptoms	04/09/23
Shilpa Medicare Limited Receives Marketing Authorization from MHRA, UK, for Betahistine Dihydrochloride Orodispersible Films, 24 mg	01/09/23
Shilpa Medicare's Manufacturing Facility in Telangana Gets Clearance from Brazilian Regulator	25/08/23
Shilpa Medicare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23
Shilpa Medicare Limited Announces Issuance of Redeemable Non-Convertible Debentures for its 2 Wholly Owned Subsidiaries	08/08/23
Shilpa Medicare Gets Regulatory Nod for Pemetrexed Injections	01/08/23
Shilpa Medicare Limited Receives Approval from CDSCO, New Delhi for Manufacturing and Sale of Lenvatinib Capsules, 12, 18 and 24 mg in India	29/06/23
Shilpa Medicare to Raise Up to INR3.25 Billion from Rights Issue	23/06/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Shilpa Medicare Limited

Actions

SHILPAMED

INE790G01031

Autres langues

Filtres